OMED - Legends to the figures.

1.0 Revision Notes

Date: January 21, 1998

Note from the American Editor applying for release in the USA:

Version 1.0g represents a U.S. revision to MST Version 1.0. This revision was reviewed by the ASGE Informatics Committee on November 15, 1997 in Washington, DC. The decision was made based on testing to include Reasons for Endoscopy and Diagnoses based on preliminary testing results. It was determined that these would be mapped to the existing ASGE Indications list and this map would be forwarded to the Standards of Practice Committee for review and modification. Furthermore, more careful analysis of the U.S. testing results would enable the U.S. representatives to make proposals for modification of the MST Version 2.0 after its publication.

2.0 MST Version 2.0 Revision Notes

2.1 General Comments

Version 2.0f is based on the analysis of the results obtained in prospective testing in Europe and the United States. The results of these testings will be published separately in scientific journals with peer review and will be summarized in the publication of the extended version of the Minimal Standard Terminology that will be proposed joinly by the Committees of the ESGE and ASGE and OMED.

2.2 Highlights on MST Changes

2.2.1 Major Sites changed to Site(s): There are no Major Sites defined in the Anatomic Sites. Major implies that there are Minor Sites. It is simpler to specify simply Site(s) which are derived from the Anatomic Site Tables.

2.2.2 Use of "Other": Other is implied in any system designed. There should always be the ability to add a Term if the list is inadequate. A choice "Other" should thus always be available, at the end of every list of terms.

2.2.3 Stomach: Hemorrhagic Mucosa: There is no need for attributes that define bleeding. A hemorrhagic mucosa must be defined as a bleeding mucosa and as such must be bleeding and stigmata are always present.

By and with the contribution of Èulogos and UniNet.